HR+/HER2- MBC 2L Outcomes: Top 10 ASCO 2025 Breakthroughs ASCO 5 Mins Read Welcome to this comprehensive web companion for the OncologyTube.com video, “HR+/HER2- metastatic breast cancer 2L outcomes: Top 10 from ASCO…
Top 10 Breast Cancer Trials to Watch at ASCO 2025: OncologyTube Exclusive ASCO 3 Mins Read The American Society of Clinical Oncology (ASCO) Annual Meeting is a pivotal event for oncology professionals, and ASCO 2025, happening…
CAPItello-291 trial for Pts with Resistant HR+/HER2- Advanced Breast Cancer A Phase 3 Study Breast Cancer 3 Mins Read by Hope Rugo, MD – UCSF Dr. Hope S. Rugo is a highly respected oncologist and professor of medicine specializing…
